I've been reading about the Phase 2 trials progressing ahead of schedule. 21 sites up and running that include some of the best brain cancer centers in the country like NYU, University of Chicago, UPenn. The way this trial is set up will leave no room for dispute when the results come in. IMUC set up this trial brilliantly. Take a look at this FDA link.
According to a recent SEC filing, over 80 patients are already enrolled in the trial. This seems to be the fastest enrollment I've seen for a GBM trial. By the time other companies like CLDX have their sites up and running, IMUC will have completed enrollment. Looking forward to seeing interim results in 2012.